University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Measles virus causes immunogenic cell death in human melanoma.

Donnelly, OG, Errington-Mais, F, Steele, L, Hadac, E, Jennings, V, Scott, K, Peach, H, Phillips, RM, Bond, J, Pandha, H , Harrington, K, Vile, R, Russell, S, Selby, P and Melcher, AA (2011) Measles virus causes immunogenic cell death in human melanoma. Gene Ther.

Full text not available from this repository.


Oncolytic viruses (OV) are promising treatments for cancer, with several currently undergoing testing in randomised clinical trials. Measles virus (MV) has not yet been tested in models of human melanoma. This study demonstrates the efficacy of MV against human melanoma. It is increasingly recognised that an essential component of therapy with OV is the recruitment of host antitumour immune responses, both innate and adaptive. MV-mediated melanoma cell death is an inflammatory process, causing the release of inflammatory cytokines including type-1 interferons and the potent danger signal HMGB1. Here, using human in vitro models, we demonstrate that MV enhances innate antitumour activity, and that MV-mediated melanoma cell death is capable of stimulating a melanoma-specific adaptive immune response.Gene Therapy advance online publication, 15 December 2011; doi:10.1038/gt.2011.205.

Item Type: Article
Divisions : Surrey research (other units)
Authors :
Donnelly, OG
Errington-Mais, F
Steele, L
Hadac, E
Jennings, V
Scott, K
Peach, H
Phillips, RM
Bond, J
Harrington, K
Vile, R
Russell, S
Selby, P
Melcher, AA
Date : 15 December 2011
DOI : 10.1038/gt.2011.205
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 09:38
Last Modified : 24 Jan 2020 17:21

Actions (login required)

View Item View Item


Downloads per month over past year

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800